Glycosyltransferase effectors from bacterial enteric pathogens

Hartland, Elizabeth (Primary Chief Investigator (PCI))

Hudson Institute - Department of Molecular and Translational Science

Project: Research

Status	Finished
Effective start/end date	1/01/18 → 31/12/19

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$772,600.00

2 Article

NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector
Giogha, C., Scott, N. E., Lung, T. W. F., Pollock, G. L., Harper, M., Goddard-Borger, E. D., Pearson, J. S. & Hartland, E. L., Jun 2021, In: PLoS Pathogens. 17, 6, 29 p., e1009658.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

6 Citations (Scopus)
The Salmonella Effector SseK3 Targets Small Rab GTPases
Gan, J., Scott, N. E., Newson, J. P. M., Wibawa, R. R., Wong Fok Lung, T., Pollock, G. L., Ng, G. Z., van Driel, I., Pearson, J. S., Hartland, E. L. & Giogha, C., 19 Aug 2020, In: Frontiers in Cellular and Infection Microbiology. 10, 17 p., 419.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

14 Citations (Scopus)